iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

Go back to iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
(NASDAQ: IMDX) Delayed: 4.13 --0 (-0%)
Previous Close $4.13    52 Week High
Open $4.13    52 Week Low
Day High $4.13    P/E N/A 
Day Low $4.13    EPS
Volume 1,662